SCHEMBL7923787

SCHEMBL7923787

Cc1cccc(C(=CCBr)c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 3/20 0.42
GPR52 Q9Y2T5 1/20 0.42
PARP1 P09874 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923784 1.00 SMN1; SMN2 (0.45) SMN1; SMN2POLBGPR52PARP1NPC1
SCHEMBL6547170 0.84 SMN1; SMN2 (0.46) SMN1; SMN2POLBGPR52PARP1NPC1
SCHEMBL27622858 0.84 NPC1 (0.48) SMN1; SMN2POLBNPC1RAB9AMEN1
SCHEMBL7535000 0.83 MTNR1A (0.47) MTNR1AMTNR1B
SCHEMBL6547639 0.81 GPR52 (0.44) SMN1; SMN2POLBGPR52PARP1NPC1
SCHEMBL10591207 0.80 SMN1; SMN2 (0.52) SMN1; SMN2POLBGPR52PARP1NPC1
SCHEMBL6546977 0.80 SMN1; SMN2 (0.52) SMN1; SMN2POLBGPR52PARP1NPC1
SCHEMBL7923653 0.79 ERCC5 (0.42) SMN1; SMN2PARP1NPC1RAB9AMEN1
SCHEMBL7923651 0.79 ERCC5 (0.42) SMN1; SMN2PARP1NPC1RAB9AMEN1
SCHEMBL7917360 0.79 MTNR1A (0.63) SMN1; SMN2GPR52PARP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174898-B1 TREATING FILARIAE IN LYMPHATIC SYSTEM BY ADMINISTERING N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS IN WHICH A SUBSTITUTED ALKYL CHAIN FORMS PART OF N-SUBSTITUENT AND SALTS NOVO NORDISK A/S (DK) 2001-01-16 US disclosed
EP-0858339-A1 A METHOD OF TREATING FILARIAE NOVO NORDISK A/S (DK) 1998-08-19 EP disclosed
EP-0502031-B1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION NOVO NORDISK AS (DK) 1997-08-20 EP disclosed
WO-1997017073-A1 A METHOD OF TREATING FILARIAE NOVO NORDISK A/S (DK) 1997-05-15 WO disclosed
US-5198451-A Treatment of epilepsy, inhibitors of gamma-aminobutyric acid uptake from synaptic cleft NOVO NORDISK A/S (DK) 1993-03-30 US disclosed
EP-0502031-A1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION. NOVO NORDISK AS (DK) 1992-09-09 EP disclosed
WO-1991007389-A1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION NOVO NORDISK A/S (DK) 1991-05-30 WO disclosed